Dr. Gangadharan Komala provides a summary of the results of his study, "Kidney Adverse Events Associated with Immune Checkpoint Inhibitor Therapy," on behalf of his colleagues.

Mr. Pierre Giguère and Dr. Swapnil Hiremath provide an overview of their study, "Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients," on behalf of their colleagues.

Drs. Calyani Ganesan, Alan Pao, and John Leppert discuss the results of their study, "Kidney Stone Events after Kidney Transplant in the United States," on behalf of their colleagues.

Dr. Hiddo J.L. Heerspink summarizes the findings of his study, "Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR," on behalf of his colleagues.

Dr. Dominic Taylor provides a summary of his study "Complex Interventions across Primary and Secondary Care to Optimize Population Kidney Health," on behalf of his colleagues.

Drs. Maria de las Mercedes Noriega and Faeq Husain-Syed discuss the results of their study "Kidney Biopsy Findings in Patients with SARS-CoV-2 Infection or After COVID-19 Vaccination," on behalf of their colleagues.

Mr. Jian Roushani and Dr. Peter G. Blake provide an overview of their study "Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics," on behalf of their colleagues.

Dr. Tristan de Nattes discusses the results of his study "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies," on behalf of his colleagues.

Drs. Rachel Patzer and Stephen Pastan discuss the results of their study "The ASCENT Intervention to Improve Access and Reduce Racial Inequalities in Kidney Waitlisting," on behalf of their colleagues.

Dr. Casey Rebholz provides a summary of the findings from the study "Metabolomic Markers of Ultra-Processed Food and Incident CKD," on behalf of her colleagues.